Product Code: ETC8842131 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Genomic medicine is transforming healthcare in the Philippines by enabling personalized treatments based on an individual`s genetic makeup. The market is being driven by advancements in genetic testing, increasing research funding, and growing awareness among healthcare professionals. The integration of genomic medicine into clinical practice is expected to improve patient outcomes for cancer, metabolic disorders, and rare genetic diseases.
The growing awareness of the benefits of genomic medicine in treating genetic disorders and chronic diseases is fueling market growth in the Philippines. The increasing integration of genomic data into clinical decision-making is improving patient outcomes. Government support for genetic research and the expansion of genome-based diagnostic services are further boosting market demand. The emergence of direct-to-consumer genomic testing services is also contributing to the growing adoption of genomic medicine.
The genomic medicine market in the Philippines faces difficulties related to affordability, limited expertise, and a fragmented healthcare system. Many genomic-based treatments and precision medicine approaches are costly, making them accessible only to a small percentage of the population. The country also lacks a sufficient number of genetic specialists, slowing the implementation of genomic medicine in mainstream healthcare. Additionally, the healthcare system`s limited digital integration hampers efficient genetic data sharing and patient management.
The shift toward precision medicine is driving demand for genomic medicine in the Philippines. Investment opportunities exist in gene therapy, targeted drug development, and genomic diagnostics. Collaborations with hospitals and research institutions can further promote advancements in this field.
The Philippine government recognizes genomic medicine as an emerging field with potential benefits for public health. Policies support research and integration of genomic medicine into mainstream healthcare, ensuring compliance with ethical standards. The DOH is working towards including genomic medicine in national health programs, making advanced diagnostics and targeted treatments more accessible to the public. Regulatory frameworks also aim to prevent misuse of genetic information.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Genomic Medicine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Genomic Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Genomic Medicine Market - Industry Life Cycle |
3.4 Philippines Genomic Medicine Market - Porter's Five Forces |
3.5 Philippines Genomic Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines Genomic Medicine Market Revenues & Volume Share, By End- User, 2021 & 2031F |
4 Philippines Genomic Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Genomic Medicine Market Trends |
6 Philippines Genomic Medicine Market, By Types |
6.1 Philippines Genomic Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines Genomic Medicine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Philippines Genomic Medicine Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Philippines Genomic Medicine Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.1.5 Philippines Genomic Medicine Market Revenues & Volume, By Paediatrics, 2021- 2031F |
6.1.6 Philippines Genomic Medicine Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.1.7 Philippines Genomic Medicine Market Revenues & Volume, By Respiratory Medicine, 2021- 2031F |
6.1.8 Philippines Genomic Medicine Market Revenues & Volume, By Rare Genetic Disorders, 2021- 2031F |
6.1.9 Philippines Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Philippines Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Genomic Medicine Market, By End- User |
6.2.1 Overview and Analysis |
6.2.2 Philippines Genomic Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Philippines Genomic Medicine Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Philippines Genomic Medicine Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.2.5 Philippines Genomic Medicine Market Revenues & Volume, By Research Institutions, 2021- 2031F |
7 Philippines Genomic Medicine Market Import-Export Trade Statistics |
7.1 Philippines Genomic Medicine Market Export to Major Countries |
7.2 Philippines Genomic Medicine Market Imports from Major Countries |
8 Philippines Genomic Medicine Market Key Performance Indicators |
9 Philippines Genomic Medicine Market - Opportunity Assessment |
9.1 Philippines Genomic Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines Genomic Medicine Market Opportunity Assessment, By End- User, 2021 & 2031F |
10 Philippines Genomic Medicine Market - Competitive Landscape |
10.1 Philippines Genomic Medicine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Genomic Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |